Falls are a leading cause of injury deaths among older adults, and some medications significantly increase this risk.

Diuretics serve as essential but symptomatic therapy in heart failure management, functioning primarily as a “bailout ...

A PwC analysis shows that GLP-1 medications like Ozempic and Zepbound may be catalyzing a behavioral and economic shift that’s on par with major technological breakthroughs. A transformation that ...

Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

Is walking 4,000 steps once or twice a week enough to reduce heart disease risk? A new study found that those who took at least 4,000 steps lowered their cardiovascular disease risk by 27%.

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to ...

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

Assessing all available nonhormonal and hormonal therapies for vasomotor symptoms helps empower women to make informed ...

The International Liaison Committee on Resuscitation conducts continuous reviews of new, peer-reviewed published ...

Ypsomed said the YpsoLoop platform integrates into existing production environments. This supports a transition toward more ...